Optimize clinical trial protocols and speed up study startup using AI-driven insights to reduce patient burden, minimize risks, and lower overall research costs.
Opyl
Opyl is an AI-powered platform specializing in clinical trial optimization and automation for biopharmaceutical companies, researchers, and investors.
About Opyl
Opyl is a leading Australian digital health company leveraging artificial intelligence to transform clinical trial design and delivery. Its flagship AI model, TrialKey, is trained on an extensive dataset of over 468,429 trials, enabling it to simulate trial scenarios more than 100,000 times. This allows Opyl to provide data-driven recommendations and forecast outcomes with over 92% accuracy in predicting trial phase completion. The platform addresses the critical challenge of high trial failure rates, often due to inadequate design, by empowering clinical researchers, biopharmaceutical corporations, and medical investors to make informed decisions, navigate complex datasets, and accelerate medical innovation, ultimately bringing treatments to market faster.
Opyl features
- data-driven recommendations
- leverages vast clinical trial data
- biostatistical validation
- 92% accuracy in phase completion prediction
- forecast clinical trial outcomes
- enhanced trial design
- clinical trial automation
- ai-powered clinical trial optimization
Ratings & reviews
No reviews yet. Be the first to share how Opyl worked for you.
Sponsored tools
Test your knowledge in live multiplayer Jeopardy-style trivia battles with AI-assisted grading that recognizes correct answers even with spelling mistakes.
Connect with engaged niche audiences or monetize your subscriber base through an automated marketplace featuring verified metrics and secure Stripe payments.
Create full vocal songs, instrumental tracks, and stem splits in seconds using intuitive text prompts, custom lyrics, and advanced AI music models.